Louisa Degenhardt | |
---|---|
Employer | University of New South Wales |
Known for | Drug and alcohol research |
Title | Professor |
Website | https://www.unsw.edu.au/staff/louisa-degenhardt |
Louisa Degenhardt is an Australian drug and alcohol researcher, and a scientia professor. [1] [2] She is also a senior principal research fellow with the National Health and Medical Research Council, part of the Centre for National Drug and Alcohol Research. She was elected as a fellow of the Australian Academy of Science in 2024. [3] [2] She received an Order of Australia in 2023. [4]
Degenhardt received her PhD in 2003. The topic was examining the comorbidity of mental disorders and drug use in the Australia and the general population. She researches of diverse epidemiological studies. These studies include clinical population surveys, analysis of large-scale community. She also works on data linkage studies, particularly on young people and/or members of the population who have either historical drug dependence or experience chronic pain.
Degenhardt has a number of honorary Professorial appointments. These include appointments at the University of Washington, as well as the University of Melbourne, in the school of Global Health and Population, and the Murdoch Children's Research Institute. [2]
Degenhardt is a fellow of numerous academies, including Fellow of the Australian Academy of Health and Medical Sciences, (2017), Fellow of the Academy of the Social Sciences in Australia, (2016), and the Fellow of the Australian Academy of Science, (2024).
Degenhardt has over 250,000 citations, an H index of 159, as at May 2024, according to Google Scholar. [5] She has published more than 45 book chapters 530 peer-reviewed papers, three books, and over 10 papers published in The Lancet. [6]
Select publications include:
Degenhardt has published in The Conversation, on topics [7] including the global burden of health due to illicit drugs and mental health, and why these are rising. [8] She has also published on Xanax, and other drugs used to treat anxiety and depression, and why the TGA may make these more difficult to receive. [9]
Matthew England is an Australian physical oceanographer and climate scientist. As of 2024 he is Scientia Professor at the Centre for Marine Science & Innovation at the University of New South Wales, Sydney.
Wayne Denis Hall (AM) is an Emeritus Professor at the National Centre for Research on Youth Substance Use Research. He was Inaugural Professor and Director of the Centre for Youth Substance Abuse Research at the University of Queensland (2013-2016), an NHMRC Australia Fellow at the University of Queensland Centre for Clinical Research (2010-2013), Professor of Public Health Policy in the School of Population Health (2005–2010) and Director of the Office of Public Policy and Ethics at Institute for Molecular Biosciences (2001–2005), at the University of Queensland. He is also a Fellow of the Academy of the Social Sciences in Australia. He has written widely on the ethical and policy issues associated with the genetics and neurobiology of addiction, mental disorders and cancer.
Michael Cowley is an Australian physiologist. He is best known for his mapping of the neural circuits involved in metabolism and obesity and diabetes treatment. He is a professor in the Department of Physiology at Monash University in the Faculty of Biomedical and Psychological Sciences. He is also a director of the Australian diabetes drug development company, Verva Inc, and director of the Monash Obesity & Diabetes Institute] (modi).
Stephen William MacMahon is a British-Australian academic medical researcher, healthcare entrepreneur and founder of The George Institute for Global Health. He holds professorial academic appointments in medicine at UNSW Sydney and Imperial College London.
Helen Christensen (AO) is the Scientia Professor of Mental Health at the University of New South Wales in Sydney. She has been the Board Director of the Black Dog Institute since 2022. She is also a former executive director and Chief Scientist at the Institute, having led the organisation from 2011 to 2021.
Katharina Gaus was a German-Australian immunologist and molecular microscopist. She was an NHMRC Senior Research Fellow and founding head of the Cellular Membrane Biology Lab, part of the Centre for Vascular Research at the University of New South Wales. Gaus used new super-resolution fluorescence microscopes to examine the plasma membrane within intact living cells, and study cell signalling at the level of single molecules to better understand how cells "make decisions". A key discovery of Gaus and her team was how T-cells decide to switch on the body's immune system to attack diseases. Her work is of importance to the development of drugs that can work with T-cells in support of the immune system.
Michelle Haber is an Australian cancer researcher in the field of childhood cancer research.
George Paxinos is a Greek Australian neuroscientist, born in Ithaca, Greece. He completed his BA in psychology at the University of California at Berkeley and his PhD at McGill University in Montreal, Canada. After a postdoctoral year at Yale University, he moved to the School of Psychology of the University of New South Wales in Sydney, Australia. He is currently an NHMRC Senior Principal Research Fellow at Neuroscience Research Australia and Scientia Professor of Medical Sciences at the University of New South Wales.
Richard Allan Bryant is an Australian medical scientist. He is Scientia Professor of Psychology at the University of New South Wales (UNSW) and director of the UNSW Traumatic Stress Clinic, based at UNSW and Westmead Institute for Medical Research. His main areas of research are posttraumatic stress disorder (PTSD) and prolonged grief disorder. On 13 June 2016 he was appointed a Companion of the Order of Australia (AC), for eminent service to medical research in the field of psychotraumatology, as a psychologist and author, to the study of Indigenous mental health, as an advisor to a range of government and international organisations, and to professional societies.
David Albert Cooper was an Australian HIV/AIDS researcher, immunologist, professor at the University of New South Wales, and the director of the Kirby Institute. He and Professor Ron Penny diagnosed the first case of HIV in Australia.
Maree Rose Teesson, FAAHMS, FASSA, is an Australian expert on mental health. She is the Director of The Matilda Centre for Research in Mental Health and Substance Use and NHMRC Principal Research Fellow at the University of Sydney. She is also professorial fellow at the Black Dog Institute, UNSW.
Terry M. McGovern is an American public health scholar. She is the Senior Associate Dean for Academic and Faculty Affairs at CUNY Graduate School of Public Health & Health Policy in New York City. McGovern is also Professor of Health Policy and Management.
Alan Frederick Cowman AC, FRS, FAA, CorrFRSE, FAAHMS, FASP, FASM is an internationally acclaimed malaria researcher whose work specialises in researching the malaria-causing parasite, Plasmodium falciparum, and the molecular mechanisms it uses to evade host responses and antimalarial drugs. As of May 2024, he is the deputy directory and Laboratory Head of the Walter and Eliza Hall Institute of Medical Research (WEHI) in Melbourne, and his laboratory continues to work on understanding how Plasmodium falciparum, infects humans and causes disease. He was elected as a fellow of the Royal Society in 2011 and awarded the Companion of the Order of Australia in 2019 for his "eminent service to the biological sciences, notably to molecular parasitology, to medical research and scientific education, and as a mentor."
Kaarin Anstey is an Australian Laureate Fellow and one of Australia's top dementia scientists. She is Co-Deputy Director of the ARC Centre of Excellence in Population Ageing Research (CEPAR) at the University of New South Wales, Australia, where she is Scientia Professor of Psychology. Kaarin Anstey is an Honorary Professor at the Australian National University and a Fellow of the Academy of the Social Sciences in Australia. She is a Director of the NHMRC Dementia Centre for Research Collaboration, Senior Principal Research Scientist at NeuRA and leads the NHMRC Centre of Research Excellence in Cognitive Health and the UNSW Ageing Futures Institute.
Rebecca Q. Ivers is an Australian academic known for her work in injury prevention and trauma care research.
Lisa Maher is Professor and head of Viral Hepatitis Epidemiology, at the Kirby Institute for Infection and Immunity, at the University of New South Wales and was made Member of the Order of Australia in 2015. She was awarded an Elizabeth Blackburn Fellowship, in Public Health from the NHMRC, in 2014. She is a fellow of the Australian Academy of Health and Medical Sciences.
Rachelle Buchbinder is an Australian rheumatologist and clinical epidemiologist. Her clinical practice is in conjunction with research involving multidisciplinary projects relating to arthritis and musculoskeletal conditions. She promotes improvement of communication with patients and health literacy in the community.
Emily Banks is an Australian epidemiologist and public health physician, working mainly on chronic disease. She is a Professor of Epidemiology and Public Health and Head of the Centre for Public Health Data and Policy at the Australian National University, and a visiting professor at the University of Oxford.
Glenda Margaret Halliday is an Australian neuroscientist. As of 2021, she is a professor at the University of Sydney and research fellow in the National Health and Medical Research Council (NHMRC). She was named 2022 NSW Scientist of the Year.